Edward E Winger

Summary

Country: USA

Publications

  1. ncbi A retrospective analysis of fondaparinux versus enoxaparin treatment in women with infertility or pregnancy loss
    Edward E Winger
    Alan E Beer Center for Reproductive Immunology and Genetics, San Francisco, CA 94111, USA
    Am J Reprod Immunol 62:253-60. 2009
  2. ncbi Elevated preconception CD56+ 16+ and/or Th1:Th2 levels predict benefit from IVIG therapy in subfertile women undergoing IVF
    Edward E Winger
    Laboratory for Reproductive Medicine and Immunology, San Francisco, CA 94111, USA
    Am J Reprod Immunol 66:394-403. 2011
  3. ncbi Birth defect rates in women using Adalimumab (Humira(®) ) to treat immunologic-based infertility in IVF patients
    Edward E Winger
    Laboratory for Reproductive Medicine and Immunology, San Francisco, CA, USA Assisted Reproduction and Gynaecology Centre, London, UK
    Am J Reprod Immunol 66:237-41. 2011
  4. ncbi Low circulating CD4(+) CD25(+) Foxp3(+) T regulatory cell levels predict miscarriage risk in newly pregnant women with a history of failure
    Edward E Winger
    Laboratory for Reproductive Medicine and Immunology, San Jose, CA, USA
    Am J Reprod Immunol 66:320-8. 2011
  5. ncbi Degree of TNF-?/IL-10 cytokine elevation correlates with IVF success rates in women undergoing treatment with Adalimumab (Humira) and IVIG
    Edward E Winger
    Laboratory for Reproductive Medicine and Immunology, San Francisco, CA 94111, USA
    Am J Reprod Immunol 65:610-8. 2011
  6. ncbi Treatment with adalimumab (Humira) and intravenous immunoglobulin improves pregnancy rates in women undergoing IVF
    Edward E Winger
    Reproductive Medicine and Immunology, Suite 2106, 611 Washington Street, San Francisco, CA 94111, USA
    Am J Reprod Immunol 61:113-20. 2009
  7. ncbi Treatment with tumor necrosis factor inhibitors and intravenous immunoglobulin improves live birth rates in women with recurrent spontaneous abortion
    Edward E Winger
    Alan E Beer Center for Reproductive Immunology and Genetics, San Francisco, CA, USA
    Am J Reprod Immunol 60:8-16. 2008
  8. ncbi CD57+ cells and recurrent spontaneous abortion
    Edward E Winger
    Alan E. Beer Laboratory for Reproductive Medicine, San Jose, CA 95119, USA
    Am J Reprod Immunol 58:311-4. 2007
  9. ncbi Update on treatment of immunologic abortion with low-dose intravenous immunoglobulin
    Raphael B Stricker
    California Pacific Medical Center, San Francisco, 94108, USA
    Am J Reprod Immunol 54:390-6. 2005
  10. ncbi Musical hallucinations in patients with Lyme disease
    Raphael B Stricker
    Department of Medicine, California Pacific Medical Center, 450 Sutter Street, Suite 1504, San Francisco, CA 94108, USA
    South Med J 96:711-5. 2003

Detail Information

Publications10

  1. ncbi A retrospective analysis of fondaparinux versus enoxaparin treatment in women with infertility or pregnancy loss
    Edward E Winger
    Alan E Beer Center for Reproductive Immunology and Genetics, San Francisco, CA 94111, USA
    Am J Reprod Immunol 62:253-60. 2009
    ..We compared the pregnancy success rates and safety parameters of fondaparinux versus enoxaparin, combined with immunotherapy, in patients with a history of miscarriage and/or infertility and coagulant defects...
  2. ncbi Elevated preconception CD56+ 16+ and/or Th1:Th2 levels predict benefit from IVIG therapy in subfertile women undergoing IVF
    Edward E Winger
    Laboratory for Reproductive Medicine and Immunology, San Francisco, CA 94111, USA
    Am J Reprod Immunol 66:394-403. 2011
    ..We sought to answer two questions: First, is there a group of patients who benefit from intravenous immunoglobulin (IVIG) in IVF? Second can this group of patients be identified by preconception blood testing?..
  3. ncbi Birth defect rates in women using Adalimumab (Humira(®) ) to treat immunologic-based infertility in IVF patients
    Edward E Winger
    Laboratory for Reproductive Medicine and Immunology, San Francisco, CA, USA Assisted Reproduction and Gynaecology Centre, London, UK
    Am J Reprod Immunol 66:237-41. 2011
    ..This study compares the birth defect rate in women using preconception TNF-? inhibitor (Adalimumab) during an in vitro fertilization (IVF) cycle to a similar population of women not using these immunologic therapies...
  4. ncbi Low circulating CD4(+) CD25(+) Foxp3(+) T regulatory cell levels predict miscarriage risk in newly pregnant women with a history of failure
    Edward E Winger
    Laboratory for Reproductive Medicine and Immunology, San Jose, CA, USA
    Am J Reprod Immunol 66:320-8. 2011
    ..Larger follow-up studies are needed for confirmation...
  5. ncbi Degree of TNF-?/IL-10 cytokine elevation correlates with IVF success rates in women undergoing treatment with Adalimumab (Humira) and IVIG
    Edward E Winger
    Laboratory for Reproductive Medicine and Immunology, San Francisco, CA 94111, USA
    Am J Reprod Immunol 65:610-8. 2011
    ..In this retrospective observational study, we investigate whether the degree of preconception cytokine elevation predicts the risk of IVF failure...
  6. ncbi Treatment with adalimumab (Humira) and intravenous immunoglobulin improves pregnancy rates in women undergoing IVF
    Edward E Winger
    Reproductive Medicine and Immunology, Suite 2106, 611 Washington Street, San Francisco, CA 94111, USA
    Am J Reprod Immunol 61:113-20. 2009
    ....
  7. ncbi Treatment with tumor necrosis factor inhibitors and intravenous immunoglobulin improves live birth rates in women with recurrent spontaneous abortion
    Edward E Winger
    Alan E Beer Center for Reproductive Immunology and Genetics, San Francisco, CA, USA
    Am J Reprod Immunol 60:8-16. 2008
    ....
  8. ncbi CD57+ cells and recurrent spontaneous abortion
    Edward E Winger
    Alan E. Beer Laboratory for Reproductive Medicine, San Jose, CA 95119, USA
    Am J Reprod Immunol 58:311-4. 2007
  9. ncbi Update on treatment of immunologic abortion with low-dose intravenous immunoglobulin
    Raphael B Stricker
    California Pacific Medical Center, San Francisco, 94108, USA
    Am J Reprod Immunol 54:390-6. 2005
    ..We now report the results of IVIG treatment in a larger group of women with this disorder...
  10. ncbi Musical hallucinations in patients with Lyme disease
    Raphael B Stricker
    Department of Medicine, California Pacific Medical Center, 450 Sutter Street, Suite 1504, San Francisco, CA 94108, USA
    South Med J 96:711-5. 2003
    ..These auditory hallucinations appear to respond to i.v. antibiotic therapy. Patients with musical hallucinations of unknown cause should be tested for infection with the Lyme disease spirochete...